Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to share news the company has posted its year end 2023 financial numbers that showed for the first time in company history, Delivra Health achieved positive Adjusted EBITDA.
The positive Adjusted EBITDA is attributed to various factors, including increased net revenue driven by higher sales in the USA. The company saw a 20% increase in net revenue compared to the previous year, with a significant contribution from the US market.
Davey emphasized that the company's focus moving forward is to continue increasing revenue and profitability across multiple markets, including Canada, the USA, international markets, and e-commerce channels. Delivra Health's portfolio includes innovative brands like Dream Water and LivRelief, offering relief from common health issues such as sleeplessness, chronic pain, and anxiety.
View source version on newsdirect.com: https://newsdirect.com/news/delivra-health-brands-sees-20-increase-in-revenue-as-company-posts-encouraging-2023-results-636077439
Delivra Health Brands Inc.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Boston New Times journalist was involved in the writing and production of this article.